| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥489.8B | ¥526.4B | -7.0% |
| Operating Income | ¥1.9B | ¥8.2B | -76.9% |
| Ordinary Income | ¥2.8B | ¥6.3B | -56.5% |
| Net Income | ¥-1.5B | ¥1.7B | -186.1% |
| ROE | -0.4% | 0.4% | - |
JMS Co., Ltd. reported FY2025 Q3 cumulative results with revenue of 489.8 billion yen (YoY -7.0%), operating income of 1.9 billion yen (YoY -76.9%), ordinary income of 2.8 billion yen (YoY -56.5%), and net income of -1.5 billion yen (YoY -186.1%). The company experienced significant profitability deterioration with operating margin declining to approximately 0.4%, as gross profit of 112.3 billion yen was almost entirely absorbed by selling, general and administrative expenses of 110.4 billion yen. Despite operational challenges, comprehensive income improved to 1.3 billion yen driven by other comprehensive income components including foreign exchange gains and valuation adjustments. Total assets increased to 864.9 billion yen from 814.3 billion yen, while equity expanded modestly to 418.3 billion yen from 409.3 billion yen. The company maintains its full-year guidance of 650 million yen operating income and 8.5 yen annual dividend despite projecting full-year net loss of 800 million yen.
Revenue declined 7.0% YoY to 489.8 billion yen, driven primarily by weakness across key geographic markets. Japan, the core market, recorded external sales of 31.7 billion yen (YoY -1.7%), while Singapore segment sales dropped significantly to 8.4 billion yen (YoY -27.6%), and Germany declined to 3.0 billion yen (YoY -10.5%). China showed relative resilience at 1.5 billion yen (YoY -13.0%). The revenue contraction reflects demand softness and reduced contribution from overseas operations. On the profit side, the decline was substantially more severe. Operating income collapsed 76.9% to 1.9 billion yen as the company failed to adjust its cost structure in line with revenue decline. Gross profit decreased moderately, but SG&A expenses remained largely fixed, resulting in near-zero operating margin of 0.4%. Segment profit for reporting segments totaled 418 million yen compared to 948 million yen in the prior year, with Japan segment profit declining 47.9% to 599 million yen, Singapore swinging from -255 million yen loss to -116 million yen loss (improvement), China turning profitable at 127 million yen versus -7 million yen loss, Philippines deepening losses to -537 million yen from -277 million yen, and Germany maintaining profitability at 345 million yen. The gap between operating income (1.9 billion yen) and ordinary income (2.8 billion yen) of approximately 0.9 billion yen reflects positive non-operating income contributions, primarily equity method investment gains of 177 million yen. The divergence between ordinary income (2.8 billion yen) and net income (-1.5 billion yen) of approximately 4.3 billion yen represents extraordinary losses and substantial tax burden, with the effective tax rate creating negative net income despite positive pre-tax income of 2.5 billion yen. This represents a revenue down, profit down pattern with disproportionate profit deterioration indicating significant operating leverage headwinds.
The company operates through five main reporting segments: Japan, Singapore (including Indonesia operations), China, Philippines, and Germany, plus other regions. Japan remains the core business with external sales of 31.7 billion yen representing approximately 64.7% of total revenue. Japan segment generated profit of 599 million yen but declined 47.9% YoY, indicating margin pressure in the home market. Singapore segment recorded external sales of 8.4 billion yen with operating loss of 116 million yen, showing improvement from the prior year loss of 255 million yen, suggesting cost structure adjustments are beginning to take effect. China segment achieved sales of 1.5 billion yen and turned profitable with 127 million yen operating income versus prior year loss of 7 million yen, marking the most significant turnaround among segments. Philippines segment remained smallest among major operations with external sales of only 51 million yen but reported substantial operating loss of 537 million yen, nearly doubling from prior year loss of 277 million yen, indicating structural challenges requiring urgent attention. Germany segment maintained stable profitability with sales of 3.0 billion yen and operating profit of 345 million yen, representing the highest margin performance among overseas segments. Material margin differences exist across segments, with Japan and Germany demonstrating positive operating leverage while Philippines represents a significant drag on consolidated profitability. The other regions category contributed 4.3 billion yen in sales with operating loss of 192 million yen.
[Profitability] ROE of -0.2% deteriorated significantly from positive territory in the prior year, reflecting the net loss position. Operating margin contracted to 0.4% from 1.6% YoY, indicating severe operating deleverage. Net profit margin turned negative at -0.2% versus 0.3% in the prior year. EBIT margin stood at approximately 0.4% with interest coverage ratio of only 0.67 times, highlighting concerning debt servicing capacity as operating profit barely covers 67% of interest expense of 2.84 billion yen. [Cash Quality] Cash and deposits increased substantially to 104.6 billion yen, up 89.8% YoY, providing short-term debt coverage of 1.59 times against short-term borrowings of 65.7 billion yen. However, working capital quality deteriorated with receivables turnover at 133 days (DSO), inventory turnover at 204 days (DIO), and cash conversion cycle extending to 265 days, all significantly above healthy levels for manufacturing operations. Working capital totaled 230.4 billion yen with inventory composition showing finished goods at 109.0 billion yen, raw materials at 63.1 billion yen, and work-in-process at 38.8 billion yen. [Investment Efficiency] Asset turnover declined to 0.566 times, reflecting both revenue contraction and asset base expansion. Financial leverage stood at 2.07 times. [Financial Health] Equity ratio improved modestly with total equity of 418.3 billion yen against total assets of 864.9 billion yen, implying approximately 48.4% equity ratio. Current ratio of 183.1% and quick ratio of 143.8% indicate adequate short-term liquidity coverage. Total liabilities of 446.6 billion yen against equity of 418.3 billion yen result in debt-to-equity ratio of 1.07 times, with debt-to-capital ratio of 32.9%. The combination of low interest coverage and extended working capital cycle presents meaningful financial risk despite reasonable leverage ratios.
Cash and deposits increased 49.5 billion yen YoY to 104.6 billion yen, representing an 89.8% expansion that significantly strengthened the liquidity position. This substantial cash accumulation occurred despite weak operating profitability, suggesting inflows from financing activities and working capital dynamics. Short-term borrowings increased 15.0 billion yen to 65.7 billion yen, providing additional liquidity but increasing interest burden as evidenced by the low interest coverage ratio of 0.67 times. The working capital composition reveals concerning trends with accounts receivable likely remaining elevated (DSO of 133 days indicates collection challenges), while inventory increased to 210.8 billion yen with particularly high finished goods balance of 109.0 billion yen suggesting sales execution difficulties. Accounts payable turnover at 71 days reflects moderate supplier credit utilization but insufficient to offset extended DSO and DIO, resulting in cash conversion cycle of 265 days that ties up substantial operational cash. Total assets expanded from 814.3 billion yen to 864.9 billion yen, an increase of 50.6 billion yen, with cash representing the predominant component of asset growth. Current assets increased to 507.7 billion yen from previous levels, driven primarily by cash and inventory, while current liabilities of 277.3 billion yen provide coverage ratio of 1.83 times. The combination of cash accumulation via external financing and deteriorating working capital efficiency creates a mixed liquidity picture where short-term solvency appears adequate at 1.59 times cash-to-short-term debt coverage, but underlying operational cash generation remains constrained by the extended cash conversion cycle and near-zero operating margins.
Ordinary income of 2.8 billion yen versus operating income of 1.9 billion yen shows non-operating net contribution of approximately 0.9 billion yen, representing positive impact from financial and investment activities. The primary components include equity method investment gains of 177 million yen and other adjustments of -11 million yen after eliminating inter-segment transactions of -116 million yen. Non-operating income represents approximately 0.2% of revenue, a modest but meaningful supplement to weak operating performance. The composition includes equity method gains as the primary contributor, indicating investment portfolio performance partially offset operational weakness. The significant divergence between ordinary income (2.8 billion yen) and net income (-1.5 billion yen) represents approximately 4.3 billion yen of negative impact, primarily from tax burden despite positive pre-tax income of 2.5 billion yen, resulting in an unusually high effective tax rate that pushed net income into negative territory. This unusual tax impact raises questions about tax timing differences or non-deductible items. Earnings quality is further impacted by comprehensive income of 1.3 billion yen substantially exceeding net income due to other comprehensive income items of approximately 2.8 billion yen, primarily foreign currency translation adjustments and valuation gains. While these items improve comprehensive income, they represent non-cash unrealized gains that do not contribute to operating cash generation. The weak operating margin of 0.4%, extended working capital cycle of 265 days, and reliance on non-operating and comprehensive income components to offset operational weakness indicate earnings quality concerns requiring careful monitoring of cash flow conversion in future periods.
The company maintains full-year guidance of 650 billion yen revenue (YoY -6.8%), operating income of 200 million yen (YoY -77.1%), ordinary income of 200 million yen (YoY -61.2%), and net loss of 800 million yen. Through Q3 cumulative period representing nine months, progress rates are: revenue 75.4%, operating income 94.5%, and ordinary income 137.5%. Revenue progress at 75.4% aligns closely with the 75% standard nine-month benchmark, suggesting full-year revenue guidance remains achievable. However, operating income progress at 94.5% indicates fourth quarter expectations of only 11 million yen, implying near-breakeven operational performance in the final quarter. Ordinary income progress exceeding 100% at 137.5% suggests fourth quarter ordinary loss expectation of approximately 755 million yen, a significant deterioration that would be driven by either non-operating losses or extraordinary items to reach the full-year net loss guidance of 800 million yen. The company projects annual dividend of 8.5 yen despite full-year net loss, indicating commitment to shareholder returns independent of current year profitability. The guidance implies fourth quarter revenue of approximately 160 billion yen to meet full-year target, which would represent sequential improvement from Q3 run rates. However, the sharp expected deterioration in ordinary and net income for Q4 warrants attention to potential non-recurring charges or seasonal factors. No explicit revision has been announced, suggesting management maintains confidence in full-year parameters despite challenging Q3 results.
The company maintains annual dividend guidance of 8.5 yen per share, unchanged from prior year. With net income of -1.5 billion yen for the nine-month period and full-year net loss projection of 800 million yen, the payout ratio calculation yields -404% on a nine-month basis, reflecting negative earnings. The dividend of 8.5 yen per share on estimated shares outstanding of approximately 24.5 million shares implies total annual dividend payment of approximately 208 million yen. Despite the net loss position, management's decision to maintain dividend reflects either commitment to shareholder returns supported by balance sheet strength and cash position, or confidence in earnings recovery in subsequent periods. Cash and deposits of 104.6 billion yen provide substantial coverage of the dividend obligation at approximately 503 times. However, sustainability of dividend policy under continued loss-making operations warrants monitoring, particularly given weak operating cash generation indicated by extended working capital cycle of 265 days and operating margin of only 0.4%. No share buyback program has been disclosed in the available data. The total return ratio incorporating only dividends against negative earnings results in undefined metrics, emphasizing the unusual nature of maintaining dividends during loss periods. The dividend yield and sustainability assessment should consider both the strong cash position and liquidity metrics (current ratio 183.1%) against the structural challenges of near-zero operating profitability and deteriorating working capital efficiency.
Working Capital Deterioration Risk: Cash conversion cycle extended to 265 days driven by receivables collection at 133 days (DSO) and inventory turnover at 204 days (DIO), both significantly exceeding healthy manufacturing benchmarks. The 210.8 billion yen inventory position with 109.0 billion yen in finished goods suggests potential obsolescence or pricing pressure risk. Extended working capital cycle constrains operational cash generation despite adequate overall liquidity position, and requires intensive focus on collection enforcement and inventory reduction initiatives.
Interest Coverage and Debt Service Risk: Interest coverage ratio of 0.67 times indicates operating profit covers only 67% of annual interest expense of 2.84 billion yen, representing material financial distress indicator. Short-term borrowings increased 29.6% to 65.7 billion yen, and while cash coverage of 1.59 times provides near-term protection, the inability to service interest from operations creates refinancing risk and limits financial flexibility for strategic investments or market downturns.
Operating Margin Compression and Fixed Cost Burden: Operating margin collapsed to 0.4% as SG&A expenses of 110.4 billion yen absorbed nearly all gross profit of 112.3 billion yen, indicating insufficient cost structure adjustment to revenue decline of 7.0%. Philippines segment operating loss of 537 million yen nearly doubled YoY, representing structural drag requiring rationalization. Without aggressive cost restructuring, additional revenue weakness would quickly translate to operating losses, and fixed cost burden limits ability to maintain profitability through demand cycles.
[Industry Position] (Reference - Proprietary Analysis)
The company's profitability metrics significantly underperform manufacturing industry medians. Net profit margin of -0.3% compares unfavorably to industry median of 6.3% (IQR: 3.2%-9.0%), placing the company in the bottom quartile. Operating margin of 0.4% substantially trails industry median of 8.3% (IQR: 4.8%-12.6%), indicating severe operational challenges relative to peers. ROE of -0.2% falls well below industry median of 5.0% (IQR: 2.9%-8.1%), while ROA similarly underperforms at an estimated level below industry median of 3.3% (IQR: 1.8%-5.2%). Revenue contraction of -7.0% contrasts sharply with industry median growth of 2.7% (IQR: -1.9% to 7.9%), suggesting company-specific market share losses or segment-specific headwinds rather than broad industry trends.
Working capital efficiency shows critical underperformance. Receivables turnover of 133 days substantially exceeds industry median of 83 days (IQR: 68-115 days), indicating collection difficulties. Inventory turnover of 204 days more than doubles industry median of 109 days (IQR: 50-155 days), highlighting significant inventory management challenges. Operating working capital cycle extends to levels well above industry median of 108 days (IQR: 72-143 days), representing material competitive disadvantage in cash conversion efficiency.
Financial health metrics present a mixed picture relative to industry benchmarks. Current ratio of 183.1% underperforms industry median of 284% (IQR: 210%-381%), though remains within acceptable range. Equity ratio of approximately 48% trails industry median of 63.8% (IQR: 49.5%-74.7%), positioning the company near the lower quartile for balance sheet strength. Financial leverage of 2.07 times exceeds industry median of 1.53 times (IQR: 1.31-1.85 times), reflecting higher financial risk profile. Asset turnover of 0.566 times aligns closely with industry median of 0.58 times (IQR: 0.42-0.66 times), suggesting asset efficiency is comparable to peers despite revenue decline.
The company's performance across profitability, working capital, and growth dimensions places it in the bottom quartile of manufacturing peers, while financial structure metrics remain in acceptable but below-median range. The primary competitive gaps exist in operating margin, working capital cycle, and revenue momentum.
(Reference: Manufacturing Industry, N=98 companies, Comparison: FY2025-Q3, Source: Proprietary analysis)
[Key Takeaways from Earnings]
Structural Profitability Challenge Requiring Cost Restructuring: The erosion of operating margin to 0.4% with SG&A expenses consuming nearly all gross profit represents the most critical earnings characteristic. Unlike temporary demand weakness, the inability to adjust fixed costs proportionally to revenue decline indicates structural cost base misalignment. The Philippines segment operating loss doubling to 537 million yen while contributing minimal revenue signals need for portfolio rationalization. Interest coverage of only 0.67 times elevates financial risk despite adequate current liquidity, creating urgency for margin restoration through cost optimization, facility consolidation, or segment rationalization actions.
Working Capital Management as Primary Cash Flow Lever: The extension of cash conversion cycle to 265 days driven by 133-day receivables turnover and 204-day inventory turnover represents the company's most significant operational inefficiency. With 210.8 billion yen tied up in inventory including 109.0 billion yen finished goods, and presumed elevated receivables balance based on DSO metrics, substantial cash remains trapped in working capital. The 49.5 billion yen cash increase to 104.6 billion yen derived partially from 15.0 billion yen borrowing expansion rather than operational generation. Aggressive working capital reduction through accelerated collections and inventory liquidation could release significant cash to reduce debt burden and improve interest coverage, representing the most direct path to financial stability independent of revenue recovery.
Dividend Sustainability Reliant on Balance Sheet Strength Not Earnings: The maintenance of 8.5 yen annual dividend despite net loss of 1.5 billion yen year-to-date and projected full-year loss of 800 million yen demonstrates commitment to shareholder returns decoupled from current profitability. With cash position of 104.6 billion yen providing 503 times coverage of approximate 208 million yen annual dividend obligation, near-term payment capacity exists. However, continuation of this policy under sustained loss-making operations and weak operating cash generation would gradually erode balance sheet strength. The earnings trend indicates dividend policy may face adjustment in future periods unless operational performance stabilizes, making the sustainability assessment dependent on management's success in executing margin recovery and working capital initiatives rather than current financial capacity alone.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.